FDA will have to lift Iclusig temporary suspension because it meets an unmet need.
Recalled drug :
-Tysabri was recalled ( label was updated, drug meets unmet medical need : drug was reintroduced 6 months later )
-Affymax was recalled ( need isn't unmet : Drug is dead)
Temporary suspension :
Rotarix : was temporarily suspended 03/2010; suspension lifted 3 months later
-Iclusig just temporarily suspended : Iclusig meets UNMET ( that's key ) needs: suspension will be lifted in 3 months
"The availability of Iclusig will improve the outcome of many patients with CML and Philadelphia-positive ALL . It is an effective therapy that meets an unmet medical need and has to date overcome all known resistant mutations in preclinical studies,"
ARIAD Announces Change to the Date of Its Third Quarter 2013 Financial Results Conference Call and Webcast to November 12, 2013
Thursday, October 31, 2013 at 4:30:00 PM ET
ARIAD Pharmaceuticals, Inc. (ARIA) today announced that it will change the date of its third quarter 2013 conference call to Tuesday, November 12, 2013, at 8:30 a.m. EST.
ARIAD to Announces Reduction in Force to Align Resources Around Ongoing Label change and FDA talks ?